Next Century Growth Investors’s Travere Therapeutics TVTX Stock Holding History

Next Century Growth Investors’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-142,450	Closed	-$2.89M	–	185
2015 Q3	$2.89M	Sell	142,450 -27,922	-16%	-$827K	0.12%	144
2015 Q2	$5.65M	Buy	170,372 +15,666	+10%	+$429K	0.19%	144
2015 Q1	$3.71M	Buy	+154,706	New	+$2.36M	0.13%	161

Other funds holding TVTX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Next Century Growth Investors's TVTX Position: Q4 2015 in Review

Next Century Growth Investors sold out of Travere Therapeutics (TVTX) in Q4 2015, closing a stake of 142,450 shares — an estimated $2.89M sold.

Next Century Growth Investors first reported a position in TVTX in Q1 2015 and held it in 3 quarters. The position peaked at $5.65M in Q2 2015. 116 funds tracked by Wall St. Rank hold TVTX as of Q4 2015.

Next Century Growth Investors reported no remaining Travere Therapeutics position as of Q4 2015 after selling out during the quarter.
Next Century Growth Investors sold 142,450 Travere Therapeutics shares in Q4 2015, an estimated $2.89M.
Next Century Growth Investors first reported a position in Travere Therapeutics in Q1 2015 and held it in 3 quarters.
Next Century Growth Investors's Travere Therapeutics position peaked at $5.65M in Q2 2015.
116 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2015.

Based on Next Century Growth Investors's 13F filing for Q4 2015, filed 12 Feb 2016.